Chief Executive Officer
Michelle Savoie is also an Associate Professor of Practical Training at the Faculty of Pharmacy, Université de Montréal and CEO, Consilio Manuque. Until July 2015, she was also CEO of Montréal InVivo.
Mrs. Savoie has over 30 years of experience in the life sciences and pharmaceutical sector. She has held strategic positions at Schering Canada, Eli Lilly Canada and Bristol-Myers Squibb and participated in several boards including those of the Quebec Network for Personalized Healthcare (PHC), Montréal InVivo and Personalized Medicine Partnership for Cancer. She currently participated on the NEOMED Institute’s and the International Congress on PHC’s boards as well as on the Fonds de solidarité FTQ – New Economy Investment Committee. She was actively involved in the creation of the Quebec Consortium for Drug Discovery, the Quebec PHC Strategy, NEOMED and the early phase clinical research initiatives.
A biochemist by training, she also completed an MBA, a Masters in Public Health, a PhD in biomedical sciences, a Masters in Law and Health policy and the Directors Education Program of the Institute of Corporate Directors.